Patents by Inventor Duncan H. Whitney

Duncan H. Whitney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210262040
    Abstract: The present invention relates to compositions and methods for molecular profiling and diagnostics for genetic disorders and cancer, including but not limited to gene expression product markers associated with cancer or genetic disorders. In particular, the present invention provides algorithms and methods of classifying cancer, for example, thyroid cancer, methods of determining molecular profiles, and methods of analyzing results to provide a diagnosis.
    Type: Application
    Filed: March 30, 2021
    Publication date: August 26, 2021
    Inventors: Giulia C. KENNEDY, Darya I. CHUDOVA, Eric T. WANG, Jonathan I. WILDE, Duncan H. Whitney, Michael Elashoff
  • Publication number: 20210040562
    Abstract: The disclosure in some aspects provides methods of determining the likelihood that a subject has lung cancer based on the expression of informative-genes. In other aspects, the disclosure provides methods for determining an appropriate diagnostic intervention plan for a subject based on the expression of informative-genes. Related compositions and kits are provided in other aspects of the disclosure.
    Type: Application
    Filed: May 15, 2020
    Publication date: February 11, 2021
    Inventors: Duncan H. Whitney, Michael Elashoff
  • Patent number: 10526655
    Abstract: The invention in some aspects provides methods of determining the likelihood that a subject has COPD based on the expression of informative-genes. In other aspects, the invention provides methods for determining an appropriate diagnostic intervention plan for a subject based on the expression of informative-genes. Related compositions and kits are provided in other aspects of the invention.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: January 7, 2020
    Assignee: Veracyte, Inc.
    Inventors: Duncan H. Whitney, Jun Luo
  • Publication number: 20160130656
    Abstract: The disclosure in some aspects provides methods of determining the likelihood that a subject has lung cancer based on the expression of informative-genes. In other aspects, the disclosure provides methods for determining an appropriate diagnostic intervention plan for a subject based on the expression of informative-genes. Related compositions and kits are provided in other aspects of the disclosure.
    Type: Application
    Filed: July 14, 2015
    Publication date: May 12, 2016
    Inventors: Duncan H. WHITNEY, Michael ELASHOFF
  • Publication number: 20160024583
    Abstract: The invention in some aspects provides methods of determining the likelihood that a subject has COPD based on the expression of informative-genes. In other aspects, the invention provides methods for determining an appropriate diagnostic intervention plan for a subject based on the expression of informative-genes. Related compositions and kits are provided in other aspects of the invention.
    Type: Application
    Filed: March 13, 2014
    Publication date: January 28, 2016
    Inventors: Duncan H. WHITNEY, Jun LUO
  • Publication number: 20150088430
    Abstract: The invention in some aspects provides methods of determining the likelihood that a subject has lung cancer based on the expression of informative-genes. In other aspects, the invention provides methods for determining an appropriate diagnostic intervention plan for a subject based on the expression of informative-genes. Related compositions and kits are provided in other aspects of the invention.
    Type: Application
    Filed: April 26, 2013
    Publication date: March 26, 2015
    Inventor: Duncan H. Whitney
  • Publication number: 20150080243
    Abstract: The disclosure in some aspects provides methods of determining the likelihood that a subject has lung cancer based on the expression of informative miRNAs. In other aspects, the disclosure provides methods for determining a treatment course for a subject based on the expression of informative-miRNAs. The disclosure also provides computer implemented methods for processing genomic information relating to miRNA expression. Related compositions and kits are provided in other aspects of the disclosure.
    Type: Application
    Filed: August 31, 2012
    Publication date: March 19, 2015
    Applicant: ALLEGRO DIAGNOSTICS CORP.
    Inventors: Duncan H. Whitney, Jun Luo
  • Publication number: 20080124714
    Abstract: Disclosed is a method for preparing nucleic acid containing biological samples for a nucleic acid integrity assay and/or multiple mutation analysis by incubating the biological sample with a stabilization solution that includes a buffer, a chelating agent and a salt.
    Type: Application
    Filed: May 16, 2005
    Publication date: May 29, 2008
    Applicant: Exact Sciences Corporation
    Inventors: Anthony P. Shuber, Duncan H. Whitney
  • Patent number: 5198912
    Abstract: Composite holograms are disclosed wherein microvoids between the holographic interference fringes are filled with a liquid crystal. The diffraction efficiency and other holographic properties of such composite holograms may be varied by external stimuli, e.g., application of an electric field of thermal energy.
    Type: Grant
    Filed: July 10, 1991
    Date of Patent: March 30, 1993
    Assignee: Polaroid Corporation
    Inventors: Richard T. Ingwall, Mark A. Troll, Duncan H. Whitney
  • Patent number: 4672093
    Abstract: A novel route to the manufacture of substituted polyacetylenes is disclosed in which polyacetylene is first reduced to render it n-type conductor and then treated with an organic halide to form an organic-substituted polyacetylene.
    Type: Grant
    Filed: June 6, 1986
    Date of Patent: June 9, 1987
    Assignee: Massachusetts Institute of Technology
    Inventors: Gary E. Wnek, Duncan H. Whitney